Presentation is loading. Please wait.

Presentation is loading. Please wait.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Published byMae Rose Modified over 6 years ago

Similar presentations

Presentation on theme: "Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo."— Presentation transcript:

1 Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience 
Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo Nishimura, MD, Ryutaro Kakinuma, MD, Hironobu Ohmatsu, MD, Yutaka Nishiwaki, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 129, Issue 5, Pages (May 2005) DOI: /j.jtcvs Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Treatment sequence. PLC, Primary lung cancer
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Customized stapler (ENDO-GIA /3–1; Tyco Healthcare Japan, Tokyo, Japan). The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Specimen vacuum reinflation.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

5 Figure 4 VvG staining showing elastic fiber destruction in type C tumor (A) and intact elastic fibers in type A tumor (B). (Magnification 100×.) The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo."

Similar presentations

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases  Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience  Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,

The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer  Keiju Aokage, MD, Junji Yoshida,
Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.

Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization?  Robert B. Cameron, MD  The Journal of Thoracic.
Ground glass opacity of the lung: The veil that needs lifting

Ground glass opacity of the lung: The veil that needs lifting
Abracadabra I, II…HeartMate 3?

Abracadabra I, II…HeartMate 3?
Form ever follows function

Form ever follows function
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Prognostic factors in clinical stage I non–small cell lung cancer

Prognostic factors in clinical stage I non–small cell lung cancer
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
The lord of the rings  Antonio Miceli, MD, PhD 

The lord of the rings  Antonio Miceli, MD, PhD 
Is tissue the issue?  Brian E. Louie, MD, MHA, MPH, FRCSC, FACS 

Is tissue the issue?  Brian E. Louie, MD, MHA, MPH, FRCSC, FACS 
Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer  Kimihiro Shimizu, MD, Junji Yoshida, MD, Mituyo.

Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer  Kimihiro Shimizu, MD, Junji Yoshida, MD, Mituyo.
STAT3, Cten, and lung cancer: Simultaneous excitement and caution

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Similar presentations

Ads by Google